In the realm of modern healthcare, ensuring the right drug dosage for each patient remains a formidable challenge, with studies revealing that up to 50% of patients on critical therapies like chemotherapy receive suboptimal doses due to individual variations in drug metabolism. This discrepancy
In the quiet corridors of cancer research, a seismic shift is stirring for those battling multiple myeloma, a blood cancer that relentlessly challenges both patients and clinicians, igniting hope for a breakthrough. Picture a patient, exhausted after rounds of treatment, hoping for a breakthrough
In the realm of regenerative medicine, a staggering challenge persists: millions of patients worldwide suffer from vascular diseases, awaiting solutions that can repair or replace damaged blood vessels, while endothelial cells, which form the critical inner lining of these vessels, hold the key to
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the realm of innovative technologies shaping the industry. Today, we’re diving into the groundbreaking work surrounding vaccine development for
In a landscape where healthcare should prioritize patient well-being above all, the Malaysian Medical Association (MMA) has raised a critical alarm about the increasing influence of corporate entities on medical decisions, threatening the ethical foundation of the profession. As articulated by its
Imagine a world where damaged hearts mend themselves, where neurodegenerative diseases like Parkinson’s are no longer a life sentence, and where spinal cord injuries don’t mean a lifetime of immobility. Stem cell therapies, particularly those derived from pluripotent stem cells (PSCs), are poised
